Press release
The Informed Scientist: Webcasts of 9th International Symposium on Hodgkin's Lymphoma
Available anywhere at any time with www.informed-scientist.org: Video presentations of internationally renown congresses in the fi
- Presentations of the world's largest international congress on Hodgkin's Lymphoma available
Bonn, 6th of October 2013 - The Informed Scientist is the foremost free medical online video-portal. Its aim is to provide worldwide access to the latest research results to as many people as possible. Scientific lectures of top international congresses in the field of life sciences can be viewed on www.informed-scientist.org in the form of state of the art webcasts.
New Congress online from the 15th of October
The 9th International Symposium on Hodgkin's Lymphoma will take place from the 12th until the 15th of October in the Cologne Gürzenich. About 1.000 scientists and medical practitioners from all over the world are going to congregate to discuss the latest findings on Hodgkin's Lymphoma with notable national and international experts.
The Informed Scientist is going to publish the presentations and results of this year's International Symposium on Hodgkin's Lymphoma from the 15th of October already. Selected video presentations will thus be available to the scientific community immediately.
Latest findings on Hodgkin's Lymphoma
The focus of the webcasts will be on study results about various new active pharmaceutical ingredients. Like Brentuximab Vedotin, for example, a specific therapeutic agent against the CD30 antigen. Scientists and medical practitioners expect that the new substances will be able to replace chemo and radiation therapies for Hodgkin's Lymphoma in the medium term. It is with great anticipation that the final evaluation of the HD13 study of the Cologne Hodgkin study group is expected, because it might challenge the current standard of therapy for Hodgkin's in early stages and suggests a further reduction in therapy for this group of patients.
All content on www.informed-scientist.org can be accessed free of charge at any time. As Dr. habil. Raimund Wieser, who initiated the video portal, explains: “The free distribution of international research results aims at helping to increase the quality of medical research worldwide. Furthermore, individuals concerned with certain ailments, such as members of self-help groups, for example, are able to get a firsthand account of the current state of affairs regarding the research related to their disease. Video webcasts are the perfect time- and location-independent medium.”
Reprint free of charge, please forward a copy.
The Informed Scientist (TIS) is a full-service provider for modern online publication of congresses in the field of life sciences. Congress organizers and scientific societies are able to reach out to their target groups worldwide through webcasts and live streams with the help of the free online platform www.informed-scientist.org.
The Informed Scientist
c/o vogelheim.tv
Bornheimer Straße 132
53119 Bonn
Germany
Iris Shafie / Felix Zimmer
shafie@informed-scientist.org
zimmer@informed-scientist.org
Tel: 0049-228/4330926
www.informed-scientist.org
twitter.com/inf_scientist
facebook.com/TheInformedScientist
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Informed Scientist: Webcasts of 9th International Symposium on Hodgkin's Lymphoma here
News-ID: 272345 • Views: …
More Releases from The Informed Scientist
Breaking new Webcasts of the World Congress in Neurology 2014
- From the 10th of May : New congress online on free medical video portal
- Presentations of CONy Congress on Controversies in Neurology in Berlin (8-10 May, 2014)
Bonn, 9th of May 2014 - The Informed Scientist is the foremost free medical online video-portal. Its aim is to provide worldwide access to the latest research results to as many people as possible. Scientific lectures of top international congresses in the field…
The Informed Scientist: Webcasts of Markers in Cancer - A joint meeting by ASCO, …
- From the 09th of November: New congress online on free medical video portal
- Presentations of Markers in Cancer: A joint meeting by ASCO, EORTC and NCI available soon
Bonn, 4th of November 2013 - The Informed Scientist is the foremost free medical online video-portal. Its aim is to provide worldwide access to the latest research results to as many people as possible. Scientific lectures of top international congresses in the…
More Releases for Hodgkin
Hodgkin Lymphoma Treatment Market Poised to Reach USD 15.70 Bn by 2030 at 8.3% C …
Opening Paragraph
According to a new report by Maximize Market Research, the global Hodgkin Lymphoma Treatment Market was valued at USD 8.98 billion in 2023 and is projected to reach nearly USD 15.70 billion by 2030, growing at a CAGR of 8.3%.
Curious to peek inside? Grab your sample copy of this report now:https://www.maximizemarketresearch.com/request-sample/124690/
Key Highlights
Market Size & CAGR: Valued at USD 8.98 Bn in 2023, forecast to grow to USD 15.70…
High Prevalence Of Non-Hodgkin Lymphoma Fuels Market Growth: The Driving Engine …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Non Hodgkin Lymphoma (NHL) Market Size Growth Forecast: What to Expect by 2025?
The market size for non hodgkin lymphoma (NHL) has consistently seen robust growth in recent times. It is anticipated to expand from $10.11 billion in 2024 to $11.01 billion in 2025, with a compound annual growth…
Breakthrough Treatments for Non-Hodgkin Lymphoma
The Business Research Company recently released a comprehensive report on the Global Non Hodgkin Lymphoma (NHL) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The non hodgkin…
Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight
The market for Non Hodgkin Lymphoma has significant unmet medical necessities in terms of demand for innovative drugs and novel technologies. This is one of the major factors behind the market witnessing rapid growth in Non Hodgkin Lymphoma segment. Past few decades have witnessed an increased level of activity with regards to development of new identification systems and drug mechanisms. In recent years, there have been an increasing number of…
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017 | Market R …
Market Research Hub (MRH) has recently published a latest market study to its online portal, which is titled as “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017” This study offers professional analysis of the current state of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Market.
Request Free Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1049067
Market Research HUB’s latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Pipeline Review, H1 2017, provides…
Non-Hodgkin Lymphoma - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Non-Hodgkin Lymphoma - Heat Map and Analysis to its growing collection of premium market research reports.
Non-Hodgkin lymphomas (NHL) are a heterogeneous group of malignancies that originate from lymphoid tissue, with varied clinical and biological features. There were an estimated 385,741 new cases of NHL and 199,630 deaths from NHL worldwide in 2012. NHLs are classified as either indolent (slow-growing)…
